Venous Thrombo-Embolism (VTE) PreventionHelps teams monitor venous thromboembolism (VTE) incidence, increase VTE prevention practices, and reduce costs and readmission rates associated with VTE
|Type:||Analytic Accelerator||Status:||Analytic Services||Revised:||2015-Aug-20|
The Venous Thrombo-Embolism (VTE) Prevention Analytics Accelerator helps teams assess VTE rates associated with hospital admissions and monitor VTE prevention practices. The VTE Analytics Accelerator includes pulmonary embolism (PE) and deep vein thrombosis (DVT).
Helps teams monitor venous thromboembolism (VTE) incidence, increase VTE prevention practices, and reduce costs and readmission rates associated with VTE
This product may leverage one or more of the following sources:
|Primary:||EMR - Clinical||See data sources of this type|
|Secondary:||Finance/Costing||See data sources of this type|
- Improved ability to identify and reduce variation in VTE prophylaxis.
- Increased ability to identify patients at risk of VTE.
- Increased use of VTE prophylaxis in high-risk patients
- Reduced incidence of VTE-related events in admitted patients.
- Reduced rates of VTE-related readmissions.
- Analyze hospital-acquired VTE cases (incidence, unit, procedure, etc.), readmissions, mortality, and other indicators to stratify risk and prioritize areas for improvement.
- Increase the percentage of high-risk patients receiving recommended prophylaxis.
- Increase the percentage of patients receiving recommended prophylaxis within 24 hours of admission.
- Increase the use of recommended VTE prophylaxis.
- Reduce hospital-acquired VTE cases.
- Reduce VTE-associated readmissions.
- Reduce VTE-associated length of stay (LOS).
- Allina Health: A Successful Approach to Improving VTE Care and Prevention across a Large Health System